Association between genetic variants in pre-MicroRNAs and survival of early-stage NSCLC

Journal of Thoracic Oncology

Volumn 8, Issue 6, 2013, Pages 703-710

  Hong, Mi Jeong ^a   Choi, Yi Young ^a   Jang, Ji Ae ^a   Jung, Hye Jin ^a   Lee, Shin Yup ^a,b   Lee, Won Kee ^a   Yoo, Seung Soo ^a,b   Lee, Jaehee ^a   Cha, Seung Ick ^a   Kim, Chang Ho ^a   Lee, Eungbae ^a,b   Jeon, Hyo Sung ^a,b   Son, Ji Woong ^c   Park, Jae Yong ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Cancer Research Institute   (South Korea)

^c Konyang University College of Medicine   (South Korea)

Author keywords

MicroRNA; Non small cell lung cancer; Polymorphism; Survival

Indexed keywords

PRE MICRORNA 146A; PRE MICRORNA 149; PRE MICRORNA 499; RNA PRECURSOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879507522     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318288dc0a     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
3. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009;136:260-271.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
5. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515-524. (Pubitemid 43345317)
6. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
7. Guan P, Yin Z, Li X, Wu W, Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 2012;31:54.
8. Skrzypski M, Dziadziuszko R, Jassem J. MicroRNA in lung cancer diagnostics and treatment. Mutat Res 2011;717:25-31.
9. Lu Y, Govindan R, Wang L, et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012;33:1046-1054.
10. Megiorni F, Pizzuti A, Frati L. Clinical significance of microRNA expression profiles and polymorphisms in lung cancer development and management. Pathol Res Int 2011;2011:780652.
11. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res 2004;32(Database issue):D109-D111. (Pubitemid 38081615)
12. Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009;30:79-84.
13. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA- 196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009;18:1183-1187.
14. Liu Z, Li G, Wei S, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010;116:4753-4760.
15. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008;118:2600-2608. (Pubitemid 351949787)
16. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-309. (Pubitemid 33096456)
17. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-60. (Pubitemid 46889722)
18. Guan P, Yin Z, Li X, Wu W, Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 2012;31:54.
19. Braig S, Mueller DW, Rothhammer T, Bosserhoff AK. MicroRNA miR- 196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010;67:3535-3548.
20. Mueller DW, Bosserhoff AK. MicroRNA miR-196a controls melanoma- associated genes by regulating HOX-C8 expression. Int J Cancer 2011;129:1064-1074.
21. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008;27:6667-6678.
22. Liu XH, Lu KH, Wang KM, et al. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 2012;12:348.
23. Lin RJ, Lin YC, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 2010;49:719-727.
24. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001;61:3986-3997. (Pubitemid 32720961)
25. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198. (Pubitemid 43357945)